Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. [electronic resource]
Producer: 20170612Description: 1036-1044 p. digitalISSN:- 1474-4457
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Bacterial Toxins -- isolation & purification
- Double-Blind Method
- Enterotoxins -- isolation & purification
- Female
- Healthy Volunteers
- Humans
- Immunization Schedule
- Immunization, Secondary -- methods
- Male
- Middle Aged
- Shock, Septic -- prevention & control
- Superantigens -- isolation & purification
- Vaccination
- Vaccines, Synthetic -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.